Literature DB >> 15799554

Changes in the management of ALS since the publication of the AAN ALS practice parameter 1999.

W G Bradley1, F Anderson, N Gowda, R G Miller.   

Abstract

OBJECTIVE: To determine if the publication in 1999 of the AAN Practice Parameter on ALS was associated with an improvement in the standard of management of the disease.
METHODS: Data on 646 patients enrolled in the ALS CARE database and on 465 patients who died in the period May 2001 to November 2002 were compared with similar data obtained from the database from 1996 to May 1999.
RESULTS: The specialty ALS clinics were the most important source of information about ALS. The internet was a source for 39%. The treatment of sialorrhea, pseudobulbar emotional lability, and failure of swallowing and breathing had all improved significantly in the period after the publication of the Practice Parameter. However many patients still did not receive a gastrostomy tube or non-invasive positive pressure ventilation when indicated by the Practice Parameter, mainly because of lack of patient compliance. Cost was the main reason why 41% of patients did not receive riluzole, though they spent a third of the cost of this medication on alternative medicines.
CONCLUSIONS: The publication of the AAN Practice Parameter was associated with improvement in the standard of care. Most cases in the database come from specialized ALS centers, and further information on the community care of ALS patients is needed.

Entities:  

Mesh:

Year:  2004        PMID: 15799554

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  11 in total

Review 1.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

2.  Accepting or declining non-invasive ventilation or gastrostomy in amyotrophic lateral sclerosis: patients' perspectives.

Authors:  L P Greenaway; N H Martin; V Lawrence; A Janssen; A Al-Chalabi; P N Leigh; L H Goldstein
Journal:  J Neurol       Date:  2015-02-17       Impact factor: 4.849

Review 3.  Amyotrophic lateral sclerosis: pathophysiology, diagnosis and management.

Authors:  Paul H Gordon
Journal:  CNS Drugs       Date:  2011-01       Impact factor: 5.749

4.  Respiratory and nutritional support in amyotrophic lateral sclerosis.

Authors:  Namita A Goyal; Tahseen Mozaffar
Journal:  Curr Treat Options Neurol       Date:  2014-02       Impact factor: 3.598

Review 5.  Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Authors:  Hans Dieter Katzberg; Michael Benatar
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

Review 6.  Nutrition and dietary supplements in motor neuron disease.

Authors:  Jeffrey Rosenfeld; Amy Ellis
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

Review 7.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 8.  Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  R G Miller; C E Jackson; E J Kasarskis; J D England; D Forshew; W Johnston; S Kalra; J S Katz; H Mitsumoto; J Rosenfeld; C Shoesmith; M J Strong; S C Woolley
Journal:  Neurology       Date:  2009-10-13       Impact factor: 9.910

Review 9.  Quality improvement in neurology: amyotrophic lateral sclerosis quality measures: report of the quality measurement and reporting subcommittee of the American Academy of Neurology.

Authors:  Robert G Miller; Benjamin Rix Brooks; Rebecca J Swain-Eng; Robert C Basner; Gregory T Carter; Patricia Casey; Adam B Cohen; Richard Dubinsky; Dallas Forshew; Carlayne E Jackson; Ed Kasarskis; Nicholas J Procaccini; Mohammed Sanjak; Fredrik P Tolin
Journal:  Neurology       Date:  2013-11-22       Impact factor: 9.910

Review 10.  Exploring targets and therapies for amyotrophic lateral sclerosis: current insights into dietary interventions.

Authors:  Shyuan T Ngo; Jia D Mi; Robert D Henderson; Pamela A McCombe; Frederik J Steyn
Journal:  Degener Neurol Neuromuscul Dis       Date:  2017-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.